Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Refresh Optive Gel Drops in Dry Eye Disease
NCT02280473Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Optive UD in dry eye syndrome (DED), sponsored by Allergan. Started Nov 2014; status: completed.
02
Drugs
Optive UD
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02280473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280473.